To provide community pharmacists with up-to-date information on the currently available antibiotics for the treatment of respiratory tract infections.
This activity is designed for community pharmacists. No prerequisites required.
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
- Discuss the current state of antimicrobial resistance among commonly seen organisms relating to respiratory tract infections (RTIs).
- Describe current antimicrobial therapies and new challenges for the treatment of RTIs.
- Assess the importance of therapy duration and compliance.
- Evaluate pharmacokinetic and pharmacodynamic considerations and appropriate uses of antibiotics for RTIs.
- Identify the utility and safety of existing and newer antibiotics in treatment of RTIs.
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for pharmacists.
CREDIT DESIGNATION STATEMENT
This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy which is approved by the Accreditation Council for Pharmacy, Education as a provider of continuing pharmacy education.
ACPE Program #064-000-05-207-H01.
This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean for Continuing Pharmacy Education, University of Tennessee College of Pharmacy.
The estimated time to complete this educational activity: 2 hours.
Release date: October 15, 2005. Expiration date: October 15, 2007.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or cosponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
This program is supported by an educational grant from sanofi-aventis.